Abstract |
VI-16, a newly synthesized flavonoid, has a hydroxy substitution at C5 position, a methoxyl substitution at C5 position, and a piperazine substitution at C7 position. Here, we firstly investigated the potential antitumor effect of VI-16 in HepG2 human hepatocarcinoma cells. The MTT assay showed that VI-16 inhibited HepG2 cell growth in a concentration- and time-dependent manner. To further investigate whether apoptosis induction contributed to the antitumor effects of VI-16, DAPI staining and Annexin-V/PI double staining were performed in our tests. The data showed that VI-16 could induce apoptotic cell death in HepG2 cells. Moreover, mechanistic studies revealed that VI-16-induced apoptosis was a caspase-dependent process by decreasing the expression of pro-caspase-3. The changes in the expression of caspase-8, capsase-9, Bax and bcl-2 after VI-16 treatment suggested that the mitochondrial pathway was involved in the apoptosis induced by VI-16. Furthermore, VI-16 could significantly increase the loss of mitochondrial membrane potential and the expression of p53. Taken together, these results demonstrated that apoptosis induced by VI-16 might be one of the mechanisms by which VI-16 acts as a preventive antitumor drug against human hepatoma.
|
Authors | Na Lu, Libin Wei, Dandan Gong, Yuan Gao, Qinsheng Dai, Zhiyu Li, Qinglong Guo |
Journal | Oncology reports
(Oncol Rep)
Vol. 27
Issue 3
Pg. 873-9
(Mar 2012)
ISSN: 1791-2431 [Electronic] Greece |
PMID | 22179765
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Caspase Inhibitors
- Flavonoids
- Proto-Oncogene Proteins c-bcl-2
- VI-16 flavonoid
- bcl-2-Associated X Protein
- Caspase 3
- Caspase 8
- Caspase 9
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects, genetics)
- Carcinoma, Hepatocellular
(drug therapy, genetics, pathology)
- Caspase 3
(genetics)
- Caspase 8
(genetics)
- Caspase 9
(genetics)
- Caspase Inhibitors
- Cell Line, Tumor
- Flavonoids
(pharmacology)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Genes, p53
- Hep G2 Cells
- Humans
- Liver Neoplasms
(drug therapy, genetics, pathology)
- Membrane Potential, Mitochondrial
(drug effects)
- Mitochondria
(drug effects, genetics)
- Proto-Oncogene Proteins c-bcl-2
(genetics)
- Signal Transduction
(drug effects)
- bcl-2-Associated X Protein
(genetics)
|